These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


245 related items for PubMed ID: 4266905

  • 1. Cellular immune reactions to human leukemia.
    Herberman RB, Rosenberg EB, Halterman RH, McCoy JL, Leventhal BG.
    Natl Cancer Inst Monogr; 1972 Dec; 35():259-66. PubMed ID: 4266905
    [No Abstract] [Full Text] [Related]

  • 2. Cellular immune reactions in human acute leukemia.
    Herberman RB.
    Hamatol Bluttransfus; 1974 Dec; 14():107-18. PubMed ID: 4615044
    [No Abstract] [Full Text] [Related]

  • 3. Immunologic studies in acute leukemia.
    Santos GW, Mullins GM, Bias WB, Anderson PN, Graziano KD, Klein DL, Burke PJ.
    Natl Cancer Inst Monogr; 1973 Jun; 37():69-75. PubMed ID: 4268325
    [No Abstract] [Full Text] [Related]

  • 4. An acute-leukemia antigen: correlation with clinical status.
    Halterman RH, Leventhal BG, Mann DL.
    N Engl J Med; 1972 Dec 21; 287(25):1272-4. PubMed ID: 4508573
    [No Abstract] [Full Text] [Related]

  • 5. Cell kinetics and chemotherapy in acute leukemia.
    Lampkin BC, McWilliams NB, Mauer AM.
    Semin Hematol; 1972 Apr 21; 9(2):211-23. PubMed ID: 4502317
    [No Abstract] [Full Text] [Related]

  • 6. [Long-term complete remissions in acute leukemia].
    Jacquillat C, Weil.
    Bull Cancer; 1969 Apr 21; 56(4):375-80. PubMed ID: 5280255
    [No Abstract] [Full Text] [Related]

  • 7. The distribution of lymphocytes with T- and B-cell surface markers in human bone marrow.
    Borella L, Sen L.
    J Immunol; 1974 Feb 21; 112(2):836-43. PubMed ID: 4591979
    [No Abstract] [Full Text] [Related]

  • 8. [Present status of therapy of acute leukemia].
    Polli E.
    Haematol Lat; 1969 Feb 21; 12(3):783-98. PubMed ID: 5273185
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of the acute leukemias.
    Bernard J, Jacquillat C, Weil M.
    Semin Hematol; 1972 Apr 21; 9(2):181-91. PubMed ID: 4553226
    [No Abstract] [Full Text] [Related]

  • 10. Sequestration of PHA-responsive cells (T-lymphocytes) in the bone marrow of leukemic children undergoing long-term immunosuppressive therapy.
    Borella L, Green AA.
    J Immunol; 1972 Nov 21; 109(5):927-32. PubMed ID: 4538718
    [No Abstract] [Full Text] [Related]

  • 11. Cell-mediated and humoral immune response to acute leukemia cells and soluble leukemia antigen--relationship to immunocompetence and prognosis.
    Gutterman JU, Hersh EM, Mavligit GM, Freireich EJ, Rossen RD, Butler WT, McCredie KB, Bodey GP, Rodriguez V.
    Natl Cancer Inst Monogr; 1973 Jun 21; 37():153-65. PubMed ID: 4576706
    [No Abstract] [Full Text] [Related]

  • 12. Mixed cell cultures of normal and leukaemic cells.
    Pegrum GD, Balfour IC, Evans CA, Middleton VL.
    J Pathol; 1973 May 21; 110(1):59-66. PubMed ID: 4269239
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Therapy of acute leukemias in the adult].
    Cipriani D, Pensabene A.
    Haematol Lat; 1969 May 21; 12(3):757-62. PubMed ID: 5273183
    [No Abstract] [Full Text] [Related]

  • 18. [Recent acquisitions in treatment of acute leukemias].
    Maurice PA.
    Praxis; 1967 Nov 30; 56(48):1630-5. PubMed ID: 5246659
    [No Abstract] [Full Text] [Related]

  • 19. Clinical correlates of in vitro effect of methotrexate on acute leukemia blasts.
    Hryniuk WM, Bishop A, Foerster J.
    Cancer Res; 1974 Oct 30; 34(10):2823-9. PubMed ID: 4547159
    [No Abstract] [Full Text] [Related]

  • 20. [Therapy of acute leukemia. Opinion of Prof. Franco Mandelli].
    Salvati A.
    Minerva Med; 1973 Jan 20; 64(4):170-2. PubMed ID: 4510268
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.